|4Feb 27, 2:59 PM ET

Berholtz Randy 4

4 · INNOVUS PHARMACEUTICALS, INC. · Filed Feb 27, 2018

Insider Transaction Report

Form 4
Period: 2018-02-23
Berholtz Randy
EVP, CORPORATE DEVELOPMENT
Transactions
  • Award

    Restricted Stock Units

    2018-02-23$0.18/sh+500,000$89,5002,675,000 total
    Exp: 2028-02-23Common Stock (500,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
  • [F2]RSU was granted on February 23, 2018. 125,000 RSUs vest on February 23, 2019; the total remaining shares vest in eight (8) pro rata equal installments, quarterly for two (2) years thereafter, subject to continued service.
  • [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.

Documents

1 file
  • 4
    form4-02272018_110236.xmlPrimary